Tuesday 9 October 2018

9 October 2018-Tuesday, 7:30-8:45: Registration

Inaugural Session- Tuesday, 9 October 2018: 8:45-10:15

Dr RK Vats, Additional Secretary, Ministry of Health & Family Welfare, Government of India

Dr Henk Bekedam, WHO Representative to India

Dr Mariângela Batista Galvão Simão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, WHO Geneva

Dr Renu Swarup, Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India

Dr Balram Bhargava, Secretary, Department of Health Research, Ministry of Health and Family Welfare, Government of India

Mr Ajay Prakash Sawhney, Secretary, Ministry of Electronics and Information Technology, Government of India

Mr Ramesh Abhishek, Secretary, Department Of Industrial Policy & Promotion, Ministry of Commerce and Industry, Government of India

Dr Arun Panda, Secretary, Ministry of Micro Small and Medium Enterprises, Government of India

Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region

Ms Preeti Sudan, Secretary, Health, Ministry of Health and Family Welfare, Government of India

Dr VK Paul, Member, NITI Aayog, Government of India

Honorable Ms Anupriya Patel, Minister of State, Health & Family Welfare, Government of India

Honorable Mr Ashwini Kumar Chaubey, Minister of State, Health & Family Welfare, Government of India

Dr Tedros Adhanom Ghebreyesus, Director General, World Health Organization (Video Address)

Honorable Dr Harsh Vardhan, Union Minister, Ministry of Science and Technology, Government of India

Release of “Position Paper-2nd World Conference on Access to Medical Products–Achieving the SDGs 2030”

Launch of “South East Asia Regulatory Network Information Sharing Platform Gateway”

Honorable Mr JP Nadda, Union Minister, Health & Family Welfare, Government of India

Group Photo

9 October 2018-Tuesday, 10:15-11:00: Tea Break

 

Tuesday 9 October 2018: Programme

GPW 13, Innovation, Manufacturing

9 October 2018-Tuesday, 11:00-12:15: Plenary Session 1: Access to Medical Products to achieve SDG 2030 Goals

Time

Plenary Session 1- Tuesday, 09 October 2018

Room

Tuesday,

11:00-12:15

Access to Medical Products to achieve SDG 2030 Goals

Chairs: Mr JP Nadda, Union Minister, Health & Family Welfare, Government of India

Dr Harsh Vardhan, Union Minister, Ministry of Science and Technology, Government of India

Special Addresses:

·         Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region

·         Ms Preeti Sudan, Secretary, Health, Ministry of Health and Family Welfare, Government of India

Plenary Hall

Keynote Addresses

1.      Dr Mariângela Batista Galvão Simão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, WHO, Switzerland- Contribution of 13th GPW for Access to Medical Products to achieve SDG 2030 Goals

2.      Dr Nata Menabde, Executive Director of the WHO Office at the United Nations, New York, USA- Health focus in 2019 UN General Assembly-NCDs and TB

3.      Dr Indu Bhushan, Chief Executive Officer, Ayushman Bharat Programme, Government of India- Universal Health Coverage in India: Bringing Healthcare to the People through National Health Protection Scheme

 

09 October, 2018-Tuesday, 12:15-13:30: Parallel Session 1- Policies to support Innovation for Medical Products (in select countries)

Time

Parallel Session 1 - Tuesday, 9 October, 2018

Room

Tuesday, 12:15-13:30

Policies to support Innovation for Medical Products (in select countries)

Chair: Dr Poonam Malakondaiah, Special Chief Secretary, Health, Medical and Family Welfare, Government of Andhra Pradesh, India

Co-chair: Dr Henk Bekedam, WHO Representative to India

Plenary Hall

Key Note Addresses:

·         Dr Mariângela Batista Galvão Simão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, WHO, Switzerland- Policy Options Promoting Innovation in Health Technologies- Select MERCOSUR Countries

·         Dr S Leigh Verbois, Assistant Commissioner for International Programs, US FDA, USA- Facilitating Access: The Role of Innovation and Competition 

·         Dr Jitendar Sharma, CEO, Andhra MedTech Zone, and Advisor, Kalam Institute of Health Technology, IndiaPolicy Initiatives to Promote Medical Devices and Diagnostics

Panelists

1.      Dr Calvin Ho, Assistant Professor, Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore- Mainstreaming Medical Ethics in Delivery for Fostering Quality and Safety of Health Services

2.      Dr Alka Sharma, Advisor, Department of Biotechnology, Ministry of Science and Technology, Government of India- Department of Biotechnology’s Supporting Role in the Innovations Ecosystem in India

3.      Dr Anil Koul, Director, CSIR-Institute of Microbial Technology, India-Towards Unipill for TB treatment

4.      Dr Pavan Asalapuram, CEO, EMPE Diagnostics, Sweden- Developing Rapid Diagnostic Solutions for Infectious Diseases: Focus on antibiotic resistance and Tuberculosis Tuberculosis & Sexually Transmitted Infections

 

09 October, 2018-Tuesday, 12:15-13:30: Parallel Session 2- State Health Ministers’ Roundtable Panel on Access to Medical Products

Time

Parallel Session 2 - Tuesday, 9 October, 2018

Room

Tuesday, 12:15-13:30

State Health Ministers’ Roundtable Panel on Access to Medical Products

Chair: Mr JP Nadda, Union Minister, Health & Family Welfare, Government of India

Co-Chair: Mr Ashwini Kumar Chaubey, Minister of State, Health & Family Welfare, Government of India

Moderated By: Dr Nata Menabde, Executive Director of the WHO Office at the United Nations, New York, USA

Board Room

Key Note Addresses:

·         Dr Balram Bhargava, Secretary, Department of Health Research,  Ministry of Science and Technology, and Director General, Indian Council for Medical Research, Government of India

·         Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region

State Health Ministers’ Interventions

Details to be circulated in Conference

 

09 October, 2018-Tuesday, 13:30-14:30: Lunch

 

09 October, 2018-Tuesday, 14:30-16:00: Parallel Session 3: Tracking Investments in Medical Products Research & Development

Time

Parallel Session 3- Tuesday, 09 October, 2018

Room

Tuesday, 14:30-16:00

Tracking Investments in Medical Products Research & Development

Chair: Dr Mariângela Batista Galvão Simão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, WHO, Switzerland

Co-chairs: Mr PN Ranjit Kumar, Joint Secretary, Ministry of AYUSH, Government of India

Plenary Hall

Key Note Address

·         Dr Mark Rohrbaugh, Special Adviser-Tech Transfer, National Institutes of Health, USA- The Role of NIH in Development of New Drugs & Vaccines

·         Mr Robert Terry, Manager-Research Policy, The Special Programme for Research and Training in Tropical Diseases, World Health Organization, Switzerland-Funding Global Health Product R&D and the Portfolio-To-Impact Model

Panelists

1.      Mr Niclas Jacobson, Deputy Director-General, Ministry of Health and Social Affairs, Sweden- Improving information in policy making for access to Medical Products

2.      Dr Vipul Chowdhary, Analyst, Policy Cures Research, Australia- Facilitating policy through tracking investments in product R&D

3.      Dr Suman Rijal, Executive Director, Drugs for Neglected Diseases (DNDi), India- Drug development project portfolio: DNDi Experience

4.      Dr Shirshendu Mukherjee, Mission Director, Biotechnology Industry Research Assistance Council, India- Grand Challenges Indian Contribution in Promoting Research & Development

 

09 October, 2018-Tuesday, 14:30-16:00: Parallel Session 4: Union Government Secretaries and Principal Secretaries from States Roundtable Panel-Progress of 1st World Conference on Access to Medical Products and Strengthening Regulation in States

Time

Parallel Session 4- Tuesday, 09 October, 2018

Room

Tuesday, 14:30-16:00

Union Government Secretaries and Principal Secretaries from States Roundtable Panel-Progress of 1st World Conference on Access to Medical Products and Strengthening Regulation in States

Chair: Ms Preeti Sudan, Secretary, Health, Ministry of Health and Family Welfare, Government of India

Co-chair: Dr Nata Menabde, Executive Director of the WHO Office at the United Nations, New York, USA

Lecture Hall 1

1.      Dr Renu Swarup, Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India

2.      Dr Balram Bhargava, Secretary, Department of Health Research,  Ministry of Science and Technology, and Director General, Indian Council for Medical Research, Government of India

3.      Mr Ramesh Abhishek, Secretary, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry, Government of India

4.      Mr Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, Government of India

5.      Mr Suresh Chandra, Secretary, Ministry of Law and  Justice, Government of India

6.      Dr Poonam Malakondaiah, Special Chief Secretary, Health, Government of Andhra Pradesh

7.      Dr J Radha Krishnan, Principal Secretary, Health, Government of Tamil Nadu

8.      Mr V Vumlunmang, Principal Secretary (Health & FW) Department of Health & Family Welfare, Government of Manipur

 

9.      Mr Rajeev Sadanandan, Additional Chief Secretary (Health), Department of Health & Family Welfare, Government of Kerala

 

10.  Mr Satish Chandra, Additional Chief Secretary (Health & FW), Department of Health & Family Welfare, Government of Punjab

11.  Mr Vivek Pandey, Secretary (Health), UT of Lakshadweep

12.  Mr Ajay Seth, Additional Chief Secretary (H&FW), Health and FW Department, Government of Karnataka

 

09 October, 2018-Tuesday, 16:00-16:30: Tea Break

 

09 October  2018-Tuesday, 16:30-18:00: Plenary Session 2: Mechanisms for Knowledge Sharing including Licensing Options for Medical Products to Facilitate Health for all

Time

Plenary Session 2- Tuesday, 9 October  2018

Room

Tuesday,

16:30-18:00

Mechanisms for Knowledge Sharing including Licensing Options for Medical Products for Health for all

Chair and Opening Remarks: Justice Prathibha M Singh, Judge, Delhi High Court, India

Co-chair: Mr Arun Singhal, Additional Secretary, Ministry of Health & Family Welfare, Government of India

Plenary Hall

Key Note Address:

·         Dr Mark Rohrbaugh, Special Advisor-Technology Transfer, National Institute of Health, USA- Intellectual Property Protection and Licensing under the Bayh-Dole Act

Panelists

1.      Mr Alok Kumar, Adviser, NITI Aayog, Government of India- Accelerated Inclusive Innovation Led Growth- Making Technology Work For Everyone

2.      Dr  Christer Backman, Senior Expert, International Relations, Medical Products Agency, Sweden- National and International Incentives to Promote Market Authorization on Pediatric Medical Products

3.      Dr Kavita Singh, Mission Director, Biotechnology Industry Research Assistance Council, India- Enabling Regulatory Ecosystem for Innovation in Health Technologies

4.      Dr  KS Kardam, Senior Joint Controller Patents and Designs, Indian Patent Office, India- IPR and Public Health: Indian Patent Office Practice

5.      Mr Guilherme Cintra, Senior Manager-IP &Trade, International Federation of Pharmaceutical Manufacturers & Association, Sweden- New Licensing Approaches For Access To Medical Products

 

09 October 2018-Tuesday, 18:00-18:30: Wrap Up Plenary Session: Summary of the Plenary and Parallel Sessions 

Time

Wrap Up Plenary Session: Summary of the Plenary and Parallel Sessions- Tuesday, 09 October 2018

Room

Tuesday, 18:00-18:30

Chair: Ms Preeti Sudan, Secretary, Health, Ministry of Health and Family Welfare, Government of India

Co-chair: Dr RK Vats, Additional Secretary, Ministry of Health and Family Welfare, Government of India;

Mr Sudhir Kumar, Joint Secretary, Ministry of Health and Family Welfare, Government of India;

Dr Eswara Reddy, Drugs Controller General of India, Central Drug Standard Control Organization, India

Plenary Hall

Plenary Session 1: Access to Medical Products to achieve SDG 2030 Goals

Presentation by Rapporteur

Plenary Session 2: Mechanisms for Knowledge Sharing including Licensing Options for Medical Products to Facilitate Health for all

Presentation by Rapporteur

Parallel Sessions 1: Policies to support Innovation for Medical Products (in select countries)

Presentation by Rapporteur

Parallel Sessions 3: Tracking Investments in Medical Products Research & Development

Presentation by Rapporteur

 

09 October 2018-Tuesday, 19:00hrs-Cultural Programme- Plenary Hall and Dinner- Restaurant (Ground Floor)